Approved Pilot and Failed Pivotal Study [Study As­sess­ment]

posted by luvblooms  – India, 2014-03-19 06:16 (4483 d 21:02 ago) – Posting: # 12661
Views: 20,845

Dear Lucas

As per my experience, this is a clear case of Scale-up gone bad (assuming that the Pilot was sone on Lab batch and Pivotal was done on Exhibit batches)

First attempt should be to do some proper in vitro studies to find out the differences between both the batches and then to take a call.

For better understanding could you confirm
a) BCS class of drug (impact of PSD)
b) type of formulation (IR /ER)
c) pH solubility and degradation profile
d) Variations in DT/dissolution observed for both the batches?
e) Any changes in pilot and pivotal study sites?

Regards

~A happy Soul~

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
354 visitors (0 registered, 354 guests [including 33 identified bots]).
Forum time: 04:19 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5